quinazolines has been researched along with Glaucoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goseki, T; Ishikawa, H; Nemoto, N; Nishimoto, H; Patil, PN; Shimizu, K; Uga, S | 1 |
Higuchi, S; Kawazu, K; Kitahara, T; Nakamura, J; Nakashima, M; Nishida, K; Sakanaka, K; Sasaki, H; Tomonari, M | 1 |
Lee, HJ; Lee, JW | 1 |
Araie, M; Hara, H; Ichikawa, M; Oku, H; Shimazawa, M | 1 |
Azuma, I | 1 |
2 review(s) available for quinazolines and Glaucoma
Article | Year |
---|---|
Bunazosin, a selective alpha1-adrenoceptor antagonist, as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Eye; Glaucoma; Humans; Neurons; Optic Nerve; Quinazolines; Receptors, Adrenergic, alpha-1; Retina; Retinal Vessels | 2005 |
[Progress in medical treatment for glaucoma].
Topics: Adrenergic alpha-Antagonists; Choroid; Dinoprost; Endothelins; Glaucoma; Humans; Intraocular Pressure; Ophthalmic Solutions; Quinazolines; Regional Blood Flow | 1993 |
3 other study(ies) available for quinazolines and Glaucoma
Article | Year |
---|---|
Possible mechanism of intraoperative floppy iris syndrome: a clinicopathological study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Glaucoma; Humans; Iris Diseases; Male; Quinazolines; Syndrome | 2008 |
Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Algorithms; Animals; Aqueous Humor; Drug Combinations; Glaucoma; Intraocular Pressure; Male; Models, Statistical; Ocular Hypertension; Ophthalmic Solutions; Quinazolines; Rabbits; Telemetry; Timolol | 2008 |
Reversible visual loss caused by combination therapy of alfuzosin and finasteride in a patient with uveitic glaucoma.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Finasteride; Glaucoma; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Vision Disorders | 2013 |